Positive update from AFT Pharma

Feb 5, 2020 | Latest News

AFT Pharmaceuticalshas licensed its Maxigesic® intravenous medicine (Maxigesic® IV) in 21 new countries across the Commonwealth of Independent States (CIS) and Central America, territories with a combined population of more than 220 million people. The agreements, which follow the registration of Maxigesic® IV in Australia and New Zealand in 2019, is part of AFT’s continuing […]

 


 

You need an active membership to keep reading

either log in via the form below or click here to subscribe

If you have recently subscribed and selected to pay by bank transfer our admin team will activate your membership once payment has cleared

Your Advertisement Here

Contact us now to discuss advertising options

Your Advertisement Here

Contact us now to discuss advertising options